201 related articles for article (PubMed ID: 7905344)
1. Evidence for a functional beta 3-adrenoceptor in man.
Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P
Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
[TBL] [Abstract][Full Text] [Related]
2. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
4. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
[TBL] [Abstract][Full Text] [Related]
5. Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.
Igawa Y; Yamazaki Y; Takeda H; Hayakawa K; Akahane M; Ajisawa Y; Yoneyama T; Nishizawa O; Andersson KE
Br J Pharmacol; 1999 Feb; 126(3):819-25. PubMed ID: 10188996
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
7. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
[TBL] [Abstract][Full Text] [Related]
8. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
9. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105
[TBL] [Abstract][Full Text] [Related]
10. Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes.
Hollenga C; Brouwer F; Zaagsma J
Br J Pharmacol; 1991 Mar; 102(3):577-80. PubMed ID: 1364822
[TBL] [Abstract][Full Text] [Related]
11. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.
Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P
Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784
[TBL] [Abstract][Full Text] [Related]
12. Role of beta-adrenergic receptor subtypes in lipolysis.
Louis SN; Jackman GP; Nero TL; Iakovidis D; Louis WJ
Cardiovasc Drugs Ther; 2000 Dec; 14(6):565-77. PubMed ID: 11300357
[TBL] [Abstract][Full Text] [Related]
13. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes.
Hollenga C; Zaagsma J
Br J Pharmacol; 1989 Dec; 98(4):1420-4. PubMed ID: 2575416
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective antagonism of beta-adrenoceptor sub-types on responses to isoprenaline in rat distal colon in vitro.
MacDonald A; Lamont M
Br J Pharmacol; 1993 Dec; 110(4):1551-5. PubMed ID: 8306100
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Hellmér J; Marcus C; Sonnenfeld T; Arner P
J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
[TBL] [Abstract][Full Text] [Related]
18. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
19. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
[TBL] [Abstract][Full Text] [Related]
20. Functional evidence that alpha 2A-adrenoceptors are responsible for antilipolysis in human abdominal fat cells.
Tarkovács G; Blandizzi C; Vizi ES
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):34-41. PubMed ID: 7908124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
